Trial Profile
Taxol [paclitaxel] in progressive or recurrent childhood brain tumors. A Pediatric Oncology Group phase II study
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2005
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Brain cancer
- Focus Therapeutic Use
- 07 Dec 2005 New trial record.